Skip to content
Telusuri untuk mempelajari tentang produk dan solusi InterSystems, peluang karier, dan banyak lagi.

Advisory: Gap in medications display if generic names not included

March 11, 2020 – Advisory: Gap in medications display if generic names not included

InterSystems has corrected a defect affecting how medications are displayed in the Clinical Viewer, when the generic name is not provided.

This problem exists for:

  • HealthShare Information Exchange 2018.1
  • HealthShare Unified Care Record 2019.1

This defect occurs when incoming medication data does not include the generic name within the Unified Care Record and subsequently is not displaying the Clinical Viewer.  This has been corrected as of 2019.1.2. This can be resolved by requesting an Ad hoc with the dev key below.

The correction for this defect is identified as dev key WRS1026 and will be included in all future product releases. It is also available via Ad hoc change file (patch) or full kit distribution by contacting the Worldwide Response Center (WRC).

If you have any questions regarding this advisory, please contact the WRC.

RELATED TOPICS

Latest Alerts & Advisories

24 July, 2025
InterSystems IRIS 2025.2 introduces the IRISSECURITY database, the new home for security data. Unlike IRISSYS, the previous home for security data, IRISSECURITY can be encrypted, which secures your sensitive data at rest. In a future version, IRISSECURITY will be mirrorable.
24 July, 2025
InterSystems is pleased to announce the General Availability (GA) of the 2025.2 release of InterSystems IRIS® data platform. This is a Continuous Delivery (CD) release. Please note that the GA versions of InterSystems IRIS for Health™ and HealthShare® Health Connect™ 2025.2 are currently withheld due to mirroring limitations introduced by security updates (details below).
11 June, 2025
Advisory ID Product & Versions Affected Risk Category & Score Explicit Requirements DP-439649 Products:
21 May, 2025
This issue affects all versions of HealthShare®:
21 May, 2025
This problem affects the following products: